Synthesis, Characterization, and Biological Evaluation of Meldrum's Acid Derivatives: Dual Activity and Molecular Docking Study.

Autor: Bukhari, Syed Nasir Abbas¹ (AUTHOR) sbukhari@ju.edu.sa, Abdelgawad, Mohamed Abdelwahab¹ (AUTHOR), Ahmed, Naveed² (AUTHOR), Amjad, Muhammad Wahab³ (AUTHOR), Hussain, Muhammad Ajaz⁴ (AUTHOR), Elsherif, Mervat A.⁵ (AUTHOR), Ejaz, Hasan⁶ (AUTHOR), Alotaibi, Nasser H.⁷ (AUTHOR), Filipović, Ignjat⁸ (AUTHOR), Janković, Nenad⁹ (AUTHOR) sbukhari@ju.edu.sa

Publikováno v: Pharmaceuticals (14248247). Feb2023, Vol. 16 Issue 2, p281. 13p.

Mesenchymal Stem Cells and Curcumin Effectively Mitigate Freund's Adjuvant- induced Arthritis via their Anti-inflammatory and Gene Expression of COX-1, IL-6 and IL-4.

Autor: Ahmed RH; Department of Zoology, Faculty of Science, Histology, Cell Biology and Genetic Division, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt., Rashad Ahmed R; Department of Zoology, Faculty of Science, Histology, Cell Biology and Genetic Division, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt., Galaly SR; Department of Zoology, Faculty of Science, Histology, Cell Biology and Genetic Division, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt., Moustafa N; Department of Zoology, Faculty of Science, Histology, Cell Biology and Genetic Division, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt., Abourehab MAS; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.; Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia., Abdelgawad MA; Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia., Ahmed OM; Department of Zoology, Faculty of Science, Physiology Division, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt., Abdul-Hamid M; Department of Zoology, Faculty of Science, Histology, Cell Biology and Genetic Division, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt.

Publikováno v: Endocrine, metabolic & immune disorders drug targets [Endocr Metab Immune Disord Drug Targets] 2024; Vol. 24 (4), pp. 468-488.